IFNB1 and plasma cell myeloma: Treatment of multiple myeloma cells with IFN-β also resulted in a decreased expression of the anti-apoptotic protein Bcl-XL, which might be an additional mechanism to shift the cells toward a pro-apoptotic state [54].